EUVIMEDEUVIMED entdecken
Crossref

Costs of TB preventive treatment: insights from five sub-Saharan African countries

S K Shrestha, O D'Silva, R M Tazinya Asong, A Vasiliu, N O Mzizi, D Vambe, N Kota, P Dlamini, T Steffy, M Lephosa, J Matchado, A Munthali und 9 weitere

The International Journal of Tuberculosis and Lung Disease · 30.10.2026 · 30 (11) · 504-510

DOI: 10.5588/ijtld.26.0301 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, erschienen am 30.10.2026. Verfasst von S K Shrestha und 20 weiteren Autor:innen. Beteiligte Einrichtung: School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada. Hauptthemen laut MEDLINE: Antitubercular Agents, Tuberculosis, Health Care Costs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND

Scaling up TB preventive treatment (TPT) is essential but hindered by operational and financial challenges, including limited cost evidence. This study estimated TPT delivery costs across five sub-Saharan African high-TB-burden countries.





METHODS

Micro-costing study was conducted from health system perspective across five clinics in Eswatini, Lesotho, Malawi, Uganda, and Tanzania. Data were collected using standardised templates covering overhead, human resources, equipment, consumables, and drugs, using bottom-up and top-down approaches. Human resource time was measured via 648 observations using time-and-motion studies, questionnaires, and timesheets. Costs are reported per patient in 2024 USD.





RESULTS

Among adults, total cost per individual ranged from US$27 to US$59 for 3 months of isoniazid plus rifapentine (3HP) and from US$22 to US$67 for 6 months of isoniazid (6H). Among children, the cost of 6H ranged from US$32 to US$80, while 3 months of daily rifampicin plus isoniazid (3RH) ranged from US$27 to US$46. Human resources and drugs were the principal cost drivers, accounting for the majority of total costs across all countries. Consultation for TPT initiation and adherence monitoring was the most time-consuming and costly activity.





CONCLUSION

TPT implementation costs extend significantly beyond drug prices. National programmes must adopt full-cost accounting that prioritises workforce efficiency and service integration to ensure sustainable scale-up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antitubercular AgentsTuberculosisHealth Care CostsHumansIsoniazidAfrica South of the SaharaRifampin

Substanzen

Antitubercular AgentsIsoniazidRifampin

Autor:innen und Institutionen

  • School of Epidemiology and Public Health, University of Ottawa, Ottawa, Canada.
  • Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA;, Baylor College of Medicine Children's Foundation, Mbabane, Eswatini.
  • Baylor College of Medicine Children's Foundation, Mbabane, Eswatini.
  • Baylor College of Medicine Children's Foundation, Maseru, Lesotho;, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Baylor College of Medicine Children's Foundation, Maseru, Lesotho.

Zitieren

APA

Shrestha, S. K., D'Silva, O., Tazinya Asong, R. M., Vasiliu, A., Mzizi, N. O., Vambe, D., Kota, N., Dlamini, P., Steffy, T., Lephosa, M., Matchado, J., Munthali, A., O'Brien, B., Ayuro, M. H., Elyanu, P., Mugerwa, M., Komba, L. B., Busigazi, E., Kay, A., …, & Zwerling, A. (2026). Costs of TB preventive treatment: insights from five sub-Saharan African countries. The International Journal of Tuberculosis and Lung Disease, 30(11), 504-510. https://doi.org/10.5588/ijtld.26.0301

Vancouver

Shrestha SK, D'Silva O, Tazinya Asong RM, Vasiliu A, Mzizi NO, Vambe D, et al. Costs of TB preventive treatment: insights from five sub-Saharan African countries. The International Journal of Tuberculosis and Lung Disease. 2026;30(11):504-510. doi:10.5588/ijtld.26.0301

BibTeX
@article{Shrestha2026,
  author = {Shrestha, S K and D'Silva, O and Tazinya Asong, R M and Vasiliu, A and Mzizi, N O and Vambe, D and Kota, N and Dlamini, P and Steffy, T and Lephosa, M and Matchado, J and Munthali, A and O'Brien, B and Ayuro, M H and Elyanu, P and Mugerwa, M and Komba, L B and Busigazi, E and Kay, A and Mandalakas, A and Zwerling, A},
  title = {Costs of TB preventive treatment: insights from five sub-Saharan African countries},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2026},
  volume = {30},
  number = {11},
  pages = {504--510},
  doi = {10.5588/ijtld.26.0301}
}
Kostenlos starten →